Genmab and AbbVie Announce Positive Topline Results from Phase 1/2 EPCORE NHL-1 Trial Evaluating Epcoritamab (DuoBody CD3xCD20) in Patients with Relapsed/Refractory...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Jun 27, 2023--
COPENHAGEN, Denmark--(BUSINESS WIRE)--Jun 27, 2023--